Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

prialt

ziconotide
  • Restricted Prialt --> Inpatient use restricted to continuation.
  • Restricted Prialt --> Initiation restricted to Outpatient Medical.
  • Restricted Miscellaneous Programs
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Prialt SOLUTION, INTRATHECAL 25 mcg/mL, 100 mcg/mL      
Comments:

PRIALT is classified as formulary status restricted for inpatients to patients that are already on the drug at admission. Initiation is restricted to the outpatient setting (Pain Clinic).

NOTE: Pharmacy should not supply vials for trial/test doses. The Pain Center is to use free samples provided by the drug company for trial/test doses. (Updated Feb 2023)

Reviewed: April 27, 2005 and March 22, 2011

Last updated: Feb. 23, 2023






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved